Cyanotech Corp (CYAN) stock
CYANOTCMedicinal Chemicals & Botanical ProductsFiscal year ends March 31
$0.70+0.00 (0.00%)
Close on Oct 19, 2026Market cap $5.11MP/E –Yield –
Cyanotech r&d expenses
Research and development expenses are spending on new products and technology.
Cyanotech's R&D Expenses for the twelve months ending Sep 30, 2025 was $380.00K, down 30.0% year over year. For fiscal 2025 it was $449.00K, down 34.8% from the year before. Over ten years it grew -1.4% a year on average. The highest annual figure on record is $923.00K in fiscal 2019.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $449.00K | -34.8% |
| FY2024 | Mar 31, 2024 | $689.00K | -10.5% |
| FY2023 | Mar 31, 2023 | $770.00K | +8.1% |
| FY2022 | Mar 31, 2022 | $712.00K | +11.4% |
| FY2021 | Mar 31, 2021 | $639.00K | +5.1% |
| FY2020 | Mar 31, 2020 | $608.00K | -34.1% |
| FY2019 | Mar 31, 2019 | $923.00K | +63.9% |
| FY2018 | Mar 31, 2018 | $563.00K | -5.1% |
| FY2017 | Mar 31, 2017 | $593.00K | -6.3% |
| FY2016 | Mar 31, 2016 | $633.00K | +22.4% |
| FY2015 | Mar 31, 2015 | $517.00K | +10.2% |
| FY2014 | Mar 31, 2014 | $469.00K | +81.8% |
| FY2013 | Mar 31, 2013 | $258.00K | -19.4% |
| FY2012 | Mar 31, 2012 | $320.00K | +13.5% |
| FY2011 | Mar 31, 2011 | $282.00K | +6.8% |
| FY2010 | Mar 31, 2010 | $264.00K | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026CQ3 2025 | Sep 30, 2025 | $78.00K | -43.1% |
| Q1 FY2026CQ2 2025 | Jun 30, 2025 | $74.00K | -11.9% |
| Q4 FY2025CQ1 2025 | Mar 31, 2025 | $101.00K | -36.5% |
| Q3 FY2025CQ4 2024 | Dec 31, 2024 | $127.00K | -22.1% |
| Q2 FY2025CQ3 2024 | Sep 30, 2024 | $137.00K | -21.7% |
| Q1 FY2025CQ2 2024 | Jun 30, 2024 | $84.00K | -56.0% |
| Q4 FY2024CQ1 2024 | Mar 31, 2024 | $159.00K | -25.7% |
| Q3 FY2024CQ4 2023 | Dec 31, 2023 | $163.00K | +53.8% |
| Q2 FY2024CQ3 2023 | Sep 30, 2023 | $175.00K | -15.0% |
| Q1 FY2024CQ2 2023 | Jun 30, 2023 | $191.00K | -22.4% |
| Q4 FY2023CQ1 2023 | Mar 31, 2023 | $214.00K | -6.6% |
| Q3 FY2023CQ4 2022 | Dec 31, 2022 | $106.00K | -47.0% |
| Q2 FY2023CQ3 2022 | Sep 30, 2022 | $206.00K | +62.2% |
| Q1 FY2023CQ2 2022 | Jun 30, 2022 | $246.00K | +57.7% |
| Q4 FY2022CQ1 2022 | Mar 31, 2022 | $229.00K | +90.8% |
| Q3 FY2022CQ4 2021 | Dec 31, 2021 | $200.00K | -5.2% |
| Q2 FY2022CQ3 2021 | Sep 30, 2021 | $127.00K | -26.6% |
| Q1 FY2022CQ2 2021 | Jun 30, 2021 | $156.00K | +15.6% |
| Q4 FY2021CQ1 2021 | Mar 31, 2021 | $120.00K | -0.8% |
| Q3 FY2021CQ4 2020 | Dec 31, 2020 | $211.00K | +44.5% |
| Q2 FY2021CQ3 2020 | Sep 30, 2020 | $173.00K | +12.3% |
| Q1 FY2021CQ2 2020 | Jun 30, 2020 | $135.00K | -27.8% |
| Q4 FY2020CQ1 2020 | Mar 31, 2020 | $121.00K | -58.0% |
| Q3 FY2020CQ4 2019 | Dec 31, 2019 | $146.00K | -32.4% |
| Q2 FY2020CQ3 2019 | Sep 30, 2019 | $154.00K | -27.0% |
| Q1 FY2020CQ2 2019 | Jun 30, 2019 | $187.00K | -10.1% |
| Q4 FY2019CQ1 2019 | Mar 31, 2019 | $288.00K | +121.5% |
| Q3 FY2019CQ4 2018 | Dec 31, 2018 | $216.00K | +52.1% |
| Q2 FY2019CQ3 2018 | Sep 30, 2018 | $211.00K | +41.6% |
| Q1 FY2019CQ2 2018 | Jun 30, 2018 | $208.00K | +46.5% |
| Q4 FY2018CQ1 2018 | Mar 31, 2018 | $130.00K | -1.5% |
| Q3 FY2018CQ4 2017 | Dec 31, 2017 | $142.00K | -0.7% |
| Q2 FY2018CQ3 2017 | Sep 30, 2017 | $149.00K | -2.0% |
| Q1 FY2018CQ2 2017 | Jun 30, 2017 | $142.00K | -14.5% |
| Q4 FY2017CQ1 2017 | Mar 31, 2017 | $132.00K | -16.5% |
| Q3 FY2017CQ4 2016 | Dec 31, 2016 | $143.00K | +8.3% |
| Q2 FY2017CQ3 2016 | Sep 30, 2016 | $152.00K | – |
| Q1 FY2017CQ2 2016 | Jun 30, 2016 | $166.00K | – |
| Q4 FY2016CQ1 2016 | Mar 31, 2016 | $158.00K | – |
| Q3 FY2016CQ4 2015 | Dec 31, 2015 | $132.00K | – |
See a number that looks wrong?